组织不可知疗法在精密瘤学的不断发展的景观
Vivek Subbiah1, Mohamed A Gouda2, Bettina Ryll3,4
1Sarah Cannon Research Institute, Nashville, Tennessee, USA.
CA: a cancer journal for clinicians
|May 30, 2024
概括
瘤不可知疗法针对的是特定的遗传异常,而不是瘤的位置. 像布罗利祖马布 ( pembrolizumab) 这样的经批准的治疗方法为具有特定生物标志物的高级固体瘤提供了个性化的选择.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 传统的癌症治疗依赖于瘤的起源,但瘤不可知疗法侧重于基因突变.
- 2017年FDA对小卫星不稳定性高 (MSI-H) 或不匹配修复缺陷 (dMMR) 瘤的pembrolizumab的批准标志着一个显著的转变.
- 随后对NTRK抑制剂和其他向疗法的批准凸显了这种方法的增长潜力.
研究的目的:
- 审查组织不可知性标和瘤学药物的景观.
- 讨论瘤不可知治疗中的理由,挑战和已批准的疗法.
- 探索患者倡导的观点和未来的前景.
主要方法:
- 审查FDA批准的瘤不可知疗法.
- 基因组生物标志物的分析驱动治疗选择.
- 检查免疫疗法,向疗法和抗体与药物合物的研究.
主要成果:
- 布罗利祖马布,NTRK抑制剂,BRAF V600E,RET融合和Her2阳性疗法证明了泛癌疗效.
- 瘤突变负担 (TMB) 和dMMR是免疫治疗的关键生物标志物.
- 这些疗法为具有特定生物标志物的高级固体瘤提供了个性化的选择.
结论:
- 瘤不可知疗法代表着一个范式的转变,超越了组织学和位置.
- 基因组生物标志物对于识别那些可以从这些治疗中受益的患者至关重要.
- 这种方法为患有晚期癌症的患者提供了个性化治疗选择和希望.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:18Cancer
48.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.4K